Open-Label Extension of EryDex Study IEDAT-04-2022
Public ClinicalTrials.gov record NCT06664853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Extension Study of EryDex in Patients With Ataxia Telangiectasia Following Participation in Study IEDAT-04-2022 (NEAT)
Study identification
- NCT ID
- NCT06664853
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Quince Therapeutics S.p.A.
- Industry
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Interventions
- Dexamethasone sodium phosphate Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 10, 2024
- Primary completion
- Jan 29, 2026
- Completion
- Jan 29, 2026
- Last update posted
- May 4, 2026
2024 – 2026
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence | Los Angeles | California | 90095 | — |
| The Johns Hopkins Hospital, Division of pediatric allergy and immunology | Baltimore | Maryland | 21289 | — |
| Saint Peter's University Hospital, Inc. | New Brunswick | New Jersey | 08901 | — |
| Cincinnati Children's Hospital, Division of neurology | Cincinnati | Ohio | 45229 | — |
| UT Health Houston, Department of pediatrics, division of child & adolescent neurology | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06664853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06664853 live on ClinicalTrials.gov.